CA
NZ
UK
AU
IND
US
• OS Therapies (OSTX) will issue a senior secured convertible note aggregating up to $10,000,000, subject to an original issue discount of 7.5%.
• The company advances its FUNCTION-DMD clinical trial
• Rigel Pharmaceuticals (NASDAQ: RIGL) appointed Alison L. Hannah, M.D. To a senior medical leadership role starting in early July.
• TransCode Therapeutics (NASDAQ: RNAZ) adjourned its 2026 annual meeting until July 20, citing pending Nasdaq review under Rule 5110.
• Veru Inc. (NASDAQ: VERU) can sell up to $21,800,000 of its common stock under a new sales arrangement.
• Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) enters a strategic collaboration with Thermo Fisher Scientific.
• Barinthus Biotherapeutics shareholders approved all proposals at its 2026 Annual General Meeting, with 17,549,280 ordinary shares represented by proxy.
apsoVision Inc. The changes bring a seasoned gastroenterologist onto the board while retaining the departing director in a paid advisory role.
• Creative Medical Technology Holdings (NASDAQ: CELZ) raised approximately $4.5 million by adjusting warrant terms with existing holders.
• Cortney Caudill stepped down from her role as Senior Vice President and Chief Operating Officer.
Please wait processing your request...